Savara Pharma
And finally this week, Savara Pharma has appointed Dr. Joseph McCracken, and Yuri Pikover to its Board of Directors.
McCracken has more than 25 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies, most recently serving as Global Head of Business Development & Licensing at Roche.
Pikover is a Managing Director of 37 Technology Ventures.
“The two bring a breadth of business development and public company experience to our team that will help achieve our long term growth objectives,” said CEO Rob Neville.